Microfracture Clinical Trial
— MfxbracingOfficial title:
Effects of Unloader Bracing in Clinical Outcome and Articular Cartilage Physiology Following Microfracture of Isolated Chondral Defects
NCT number | NCT02016300 |
Other study ID # | oss-mfx-2013 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2013 |
Est. completion date | June 2018 |
Verified date | May 2019 |
Source | Stanford University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study will examine clinical and radiographic outcomes of microfracture surgery (a common
technique to address isolated areas of cartilage loss) in the knee used with or without
unloader bracing. Randomly selected patients will wear an unloader brace, which is designed
to take pressure off the area of the knee which underwent repair, for several weeks after
surgery. Our hypothesis is that bracing may improve clinical and or radiographic outcomes.
The surgery performed will be the same for all patients
The length of follow up and schedule of post-operative MRI will be the same for all patients.
The only difference in groups will be presence of absence of brace wear.
Status | Completed |
Enrollment | 24 |
Est. completion date | June 2018 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 15 Years to 40 Years |
Eligibility |
Inclusion Criteria: - isolated chondral defect of medial or lateral femoral condyle 2cm squared or less - age 15-40 - neutral knee alignment Exclusion Criteria: - prior cartilage procedures performed in the same knee - other significant knee pathology including meniscus tears, ligament tears or inflammatory arthritis |
Country | Name | City | State |
---|---|---|---|
United States | Stanford University Medical Center | Redwood City | California |
Lead Sponsor | Collaborator |
---|---|
Stanford University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Knee Injury and Osteoarthritis Outcome Score (KOOS) (Clinical Outcome) | KOOS is a validated outcome score that evaluates knee symptoms, knee pain, knee use in activities of daily living, function in sport and recreation and knee-related quality of life. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved. | 2 years | |
Secondary | Change From Baseline in Tegner Score (Clinical Outcome) | The Tegner activity level scale is a graduated list of activities of daily living, recreation, and competitive sports. The patient is asked to select the level of participation that best describes their current level of activity and that before injury. A score of 0 represents sick leave or disability pension because of knee problems, whereas a score of 10 corresponds to participation in national and international elite competitive sports. A score >6 can only be achieved if the person participates in recreational or competitive sport. | 2 years | |
Secondary | Change From Baseline in SF-12 Quality of Life Score (Clinical Outcome) | SF-12 scale is a generic, multipurpose short-form survey with 12 questions selected from the SF-36 Health Survey which, when combined, scored and weighted, results in two scales of mental and physical functioning and overall health-related quality of life. A higher value indicates a better quality of life of the patient. The scores range from 0 to 100. | 2 years | |
Secondary | Change From Baseline in Lysholm Score (Clinical Outcome) | The Lysholm score is an indexed score of knee functional ability, with 0 being the worst score and 100 being the best score, indicating no limitations in activity/function. | 2 years | |
Secondary | Change From Baseline in T2 Relaxation Time (Radiographic Outcome) | T2 imaging assesses hydration of cartilage as well as collagen fiber orientation and loss of type II collagen. | 2 years | |
Secondary | Change From Baseline in Cartilage Volume (Radiographic Outcome) | 2 years | ||
Secondary | Change From Baseline in Cartilage Thickness (Radiographic Outcome) | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03064399 -
Microfracture Technique for Talar Articular Cartilage Lesions With or Without Lateral Ligament Repairment
|
N/A | |
Withdrawn |
NCT05741983 -
AMIC vs. MFx in the Ankle
|
N/A |